Stanczak et al.12 have reported the upregulation of SIGLECs including SIGLEC9 on tumor-infiltrating T cells from non-small cell lung cancer, colorectal cancer, and ovarian cancer. Here, SIGLEC9 is linked to non-small cell lung carcinoma.